These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 9347205

  • 21. Bone density in women receiving Norplant implants for contraception.
    Intaraprasert S, Taneepanichskul S, Theppisai U, Chaturachinda K.
    J Med Assoc Thai; 1997 Nov; 80(11):738-41. PubMed ID: 9385772
    [Abstract] [Full Text] [Related]

  • 22. Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. The WHO Study of Hormonal Contraception and Bone Health.
    Petitti DB, Piaggio G, Mehta S, Cravioto MC, Meirik O.
    Obstet Gynecol; 2000 May; 95(5):736-44. PubMed ID: 10775740
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pregnancy after removal of Norplant implants contraceptive.
    Affandi B, Santoso SS, Djajadilaga, Hadisaputra W, Moeloek FA, Prihartono J, Lubis F, Samil RS.
    Contraception; 1987 Aug; 36(2):203-9. PubMed ID: 3123134
    [Abstract] [Full Text] [Related]

  • 25. Long-acting hormonal contraception: assessing impact on bone density, weight, and mood.
    Kaunitz AM.
    Int J Fertil Womens Med; 1999 Aug; 44(2):110-7. PubMed ID: 10338269
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Status of bone mineral density after the long-standing application of contraception Depo-Provera].
    Zeman S, Havlík P, Zemanová J, Němec D.
    Ceska Gynekol; 2013 Jan; 78(1):116-24. PubMed ID: 23607391
    [Abstract] [Full Text] [Related]

  • 28. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
    Cromer BA, Smith RD, Blair JM, Dwyer J, Brown RT.
    Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Prevalence of Low Bone Mass and Osteoporosis in Long-Term Users of the Injectable Contraceptive Depot Medroxyprogesterone Acetate.
    Modesto W, Bahamondes MV, Bahamondes L.
    J Womens Health (Larchmt); 2015 Aug; 24(8):636-40. PubMed ID: 26098552
    [Abstract] [Full Text] [Related]

  • 33. Long-term assessment of forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
    Viola AS, Castro S, Marchi NM, Bahamondes MV, Viola CF, Bahamondes L.
    Contraception; 2011 Aug; 84(2):122-7. PubMed ID: 21757052
    [Abstract] [Full Text] [Related]

  • 34. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception.
    London RS.
    J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530
    [Abstract] [Full Text] [Related]

  • 35. Immunohistochemical staining of von Willebrand factor in endometrium of women during the first year of Norplant implants use.
    Au CL, Affandi B, Rogers PA.
    Contraception; 1994 Nov; 50(5):477-89. PubMed ID: 7859456
    [Abstract] [Full Text] [Related]

  • 36. Forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
    Sanches L, Marchi NM, Castro S, Juliato CT, Villarroel M, Bahamondes L.
    Contraception; 2008 Nov; 78(5):365-9. PubMed ID: 18929732
    [Abstract] [Full Text] [Related]

  • 37. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
    Said S, Sadek W, Rocca M, Koetsawang S, Kirwat O, Piya-Anant M, Dusitsin N, Sethavanich S, Affandi B, Hadisaputra W, Kazi A, Ramos RM, d'Arcangues C, Belsey EM, Noonan E, Olayinka I, Pinol A.
    Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
    [Abstract] [Full Text] [Related]

  • 38. Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial.
    Hofmeyr GJ, Singata-Madliki M, Batting J, Balakrishna Y, Morroni C.
    BMC Womens Health; 2024 Mar 08; 24(1):167. PubMed ID: 38459552
    [Abstract] [Full Text] [Related]

  • 39. Forearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate.
    Perrotti M, Bahamondes L, Petta C, Castro S.
    Fertil Steril; 2001 Sep 08; 76(3):469-73. PubMed ID: 11532466
    [Abstract] [Full Text] [Related]

  • 40. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ, Conway AJ, Howe CJ, Turner L, Mackey MA.
    J Clin Endocrinol Metab; 1996 Nov 08; 81(11):4113-21. PubMed ID: 8923869
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.